US House Appropriators Keep A Bullseye On FDA’s CBD Regulation Development

Appropriations subcommittee notes the funding in summary of its draft budget bill. Language on FDA’s development of CBD regulatory framework will be included in panel’s report to be released 24 hours before full committee’s markup.

US map-cannibis-plants

US House appropriators propose including funding for the Food and Drug Administration to develop a regulatory framework for allowing cannabidiols’ use in non-drug products in the agency’s fiscal year 2021 budget.

The Appropriations Committee’s subcommittee for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies on 6 July passed draft budget legislation for

More from Cannabis/CBD

More from Ingredients & Safety